Closing a Key Gap in DSCSA Compliance
Outlining the work of the Open Credentialing Initiative in establishing digital proof of identity, licensure status, and authorship using digital wallets and verifiable credentials
Tech storytelling
Since I plunged myself into the SSI world not too long ago, I’ve been both a learner within a new professional area and increasingly someone trying to explain what I do to others. Unsurprisingly, in both roles […]
COVID-19 test kits
It seems that after an initial frenzy at the start of the COVID-19 pandemic, when seemingly almost any old test could somehow make it on the market (check out the April news review for comments on quality issues), […]
Spiffin’ coronavirus vaccine
The purpose of a vaccine is effectively to train the immune system in recognising and combatting the virus quickly should there ever be a real infection. To do so, vaccines deliver virus components, which are harmless on […]
Welcome to Bio-Babel
Working across disciplines can be confusing, not only due to professional jargon but also due to basic terminology being used interchangeably by different people or media sources. This is very true in the biomedical sphere. After a […]
Supply chain innovation with blockchain
Optimising supply chain management provides several tremendous use cases for blockchain applications. Below is a quick summary of two very informative blockchain discussions on supply chain transformation that provide some useful overviews across different industries and various […]
Blue Steens in October 2020
Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, more interesting […]
Blue Steens in Aug-Sep 2020
Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, test kits […]
Plasma vs virus
Convalescent plasma (CP) therapy gained FDA emergency use authorisation (EUA) in August. It appears that this is surrounded by some controversy and suspicion of politicisation. Without getting anywhere near politics here, let’s not forget that health agencies’ […]